Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Toxicology ; 376: 66-74, 2017 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-27181935

RESUMO

The lasiodiplodan (LS) is a ß-(1→6)-d-glucan produced by the fungus Lasiodiplodia theobromae and some of the biological activities of LS were reported as hypoglycemic, anticoagulant, anti-proliferative and anticancer action; however, its effects on DNA instability and modulation of gene expression are still unclear. Aims of study were investigate the genotoxic effects of lasiodiplodan, and its protective activity against DNA damage induced by doxorubicin (DXR) and its impact on the expression of genes associated with DNA damage and inflammatory response pathways. Therefore, Wistar rats were treated (15 days) orally with LS (5.0; 10 and 20mg/kg bw) alone and in combination with DXR (15mg/kg bw; administrated intraperitoneally on 14th day) as well as their respective controls: distilled water and DXR. Monitoring of DNA damage was assessed by comet and micronucleus (MN) assays and gene expression was evaluated by PCR-Arrays. Treatments with LS alone did not induce disturbances on DNA; when LS was given in combination with DXR, comet and MN formations were reduced to those found in the respective controls. Moreover, LS was able to reduce the disturbances on gene expressions induced by DXR treatment, since the animals that receive LS associated with DXR showed no alteration in the expression of genes related to DNA damage response. Also, DXR induced several up- and down-regulation of several genes associated to inflammatory process, while the animals that received LS+DXR had their gene expression patterns similar to those found in the control group. In conclusion, our results showed that LS did not induce disturbances on DNA stability and significantly reduce the DNA damage and inflammation caused by DXR exposure. In addition, we give further information concerning the molecular mechanisms associated to LS protective effects which seems to be a promising nutraceutical with chemopreventive potential.


Assuntos
Análise Citogenética , Dano ao DNA/efeitos dos fármacos , Doxorrubicina/toxicidade , Polissacarídeos Fúngicos/farmacologia , Mediadores da Inflamação/antagonistas & inibidores , Zearalenona/análogos & derivados , Animais , Antibióticos Antineoplásicos/toxicidade , Análise Citogenética/métodos , Dano ao DNA/fisiologia , Relação Dose-Resposta a Droga , Expressão Gênica , Mediadores da Inflamação/metabolismo , Masculino , Substâncias Protetoras/farmacologia , Ratos , Ratos Wistar , Zearalenona/farmacologia
2.
Teratog Carcinog Mutagen ; 21(6): 383-93, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11746252

RESUMO

Centratherin is a sesquiterpene lactone known for its antimicrobial, anti-inflammatory, and trypanocidal activities. The aim of this study was to determine the clastogenic and cytotoxic potential of centratherin in human lymphocytes and in mice. Human lymphocytes in culture were submitted to either continuous treatment or treatment during G(2) phase of the cell cycle. After continuous treatment the 0.2 microg/ml concentration induced a significant increase in total of chromosomal aberrations (CA) and sister chromatid exchange compared to control, and it reduced the mitotic index (MI). In the treatment during G(2) phase, centratherin induced a significant increase in the frequency of CA for all concentrations tested (0.1, 0.3, and 0.5 microg/ml). In the in vivo test system all three concentrations tested in mice (3.3, 6.7, and 13.3 mg/kg b.w.) induced a significant increase in CA compared to the negative control. On the basis of these results, centratherin showed clastogenic and cytotoxic activity on in vitro and in vivo mammalian systems.


Assuntos
Mutagênicos/toxicidade , Sesquiterpenos/toxicidade , Animais , Células Cultivadas , Aberrações Cromossômicas , Feminino , Fase G2/efeitos dos fármacos , Humanos , Lactonas/toxicidade , Linfócitos/efeitos dos fármacos , Linfócitos/ultraestrutura , Masculino , Camundongos , Troca de Cromátide Irmã/efeitos dos fármacos
3.
Cancer Detect Prev ; 25(1): 93-101, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11270427

RESUMO

Lychnopholide (LNP), a sesquiterpene lactone with antitumor, trypanocidal, and antimicrobial activities, was isolated from Vanillosmopsis erythropappa. The present study was carried out to assess the cytotoxic and clastogenic potential of this new agent in human cultured lymphocytes and Swiss bone marrow cells before the agent was used in medicine. The mitotic index, chromosomal aberrations (CAs), sister chromatid exchanges (SCEs), and proliferation index were investigated. There was no alteration in the number of CAs and SCEs in the continuous in vitro treatment. However, the highest concentration (0.2 microg/ml) of LNP was cytotoxic. LNP (0.1, 0.2, and 0.4 microg/ml) induced a significant increase in CA frequency at the G2 phase in all treated cultures. Only the highest concentration (26.67 mg/kg) caused a significant increase in the total number of CAs in the in vivo investigation. On the basis of these results, LNP had a clastogenic effect on both test systems and a cytotoxic effect in vitro.


Assuntos
Aberrações Cromossômicas , Adulto , Animais , Antineoplásicos/toxicidade , Células da Medula Óssea , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Feminino , Humanos , Lactonas/farmacologia , Linfócitos , Masculino , Camundongos , Índice Mitótico , Testes de Mutagenicidade , Mutagênicos/toxicidade , Sesquiterpenos/farmacologia , Troca de Cromátide Irmã
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...